Mirum Pharmaceuticals IncNASDAQ:MIRM
- LAST PRICE24.0300
- TODAY'S CHANGE (%)-0.4100 (-1.6776%)
- Bid / Lots23.5000/ 1
- Ask / Lots25.6500/ 1
- Open / Previous Close24.5400 / 24.4400
- Day Range
- 52 Week Range
- Volume565,910
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIRM |
|---|---|---|
| 09:32 ET | 3018 | 24.65 |
| 09:34 ET | 1807 | 24.48 |
| 09:36 ET | 600 | 24.51 |
| 09:39 ET | 200 | 24.465 |
| 09:41 ET | 1100 | 24.4 |
| 09:43 ET | 1000 | 24.655 |
| 09:45 ET | 1106 | 24.6 |
| 09:48 ET | 400 | 24.51 |
| 09:50 ET | 1300 | 24.72 |
| 09:52 ET | 1098 | 24.715 |
| 09:54 ET | 300 | 24.71 |
| 09:56 ET | 7273 | 24.62 |
| 09:57 ET | 800 | 24.54 |
| 09:59 ET | 800 | 24.55 |
| 10:01 ET | 400 | 24.45 |
| 10:03 ET | 400 | 24.47 |
| 10:06 ET | 200 | 24.425 |
| 10:08 ET | 1690 | 24.52 |
| 10:10 ET | 300 | 24.515 |
| 10:12 ET | 600 | 24.455 |
| 10:14 ET | 200 | 24.435 |
| 10:15 ET | 1900 | 24.45 |
| 10:17 ET | 3776 | 24.57 |
| 10:19 ET | 500 | 24.665 |
| 10:21 ET | 965 | 24.735 |
| 10:24 ET | 100 | 24.72 |
| 10:26 ET | 3230 | 24.7 |
| 10:30 ET | 1300 | 24.6975 |
| 10:32 ET | 400 | 24.7 |
| 10:33 ET | 389 | 24.67 |
| 10:35 ET | 100 | 24.66 |
| 10:37 ET | 100 | 24.7 |
| 10:39 ET | 700 | 24.765 |
| 10:42 ET | 100 | 24.93 |
| 10:44 ET | 200 | 24.88 |
| 10:46 ET | 600 | 24.89 |
| 10:48 ET | 708 | 24.86 |
| 10:50 ET | 100 | 24.83 |
| 10:51 ET | 661 | 24.905 |
| 10:53 ET | 300 | 24.91 |
| 10:55 ET | 400 | 24.91 |
| 10:57 ET | 1885 | 24.86 |
| 11:00 ET | 700 | 24.83 |
| 11:02 ET | 100 | 24.79 |
| 11:04 ET | 602 | 24.74 |
| 11:06 ET | 200 | 24.74 |
| 11:08 ET | 200 | 24.74 |
| 11:09 ET | 5693 | 24.73 |
| 11:13 ET | 1983 | 24.83 |
| 11:20 ET | 736 | 24.77 |
| 11:24 ET | 400 | 24.74 |
| 11:26 ET | 829 | 24.81 |
| 11:27 ET | 200 | 24.86 |
| 11:31 ET | 496 | 24.64 |
| 11:38 ET | 250 | 24.59 |
| 11:40 ET | 800 | 24.615 |
| 11:45 ET | 1569 | 24.62 |
| 11:47 ET | 100 | 24.38 |
| 11:51 ET | 300 | 24.42 |
| 11:54 ET | 710 | 24.45 |
| 11:58 ET | 1700 | 24.41 |
| 12:00 ET | 100 | 24.39 |
| 12:02 ET | 700 | 24.365 |
| 12:03 ET | 200 | 24.37 |
| 12:05 ET | 130 | 24.34 |
| 12:14 ET | 2062 | 24.2902 |
| 12:16 ET | 751 | 24.37 |
| 12:18 ET | 104 | 24.4567 |
| 12:20 ET | 300 | 24.455 |
| 12:21 ET | 400 | 24.36 |
| 12:23 ET | 600 | 24.39 |
| 12:25 ET | 489 | 24.37 |
| 12:32 ET | 100 | 24.39 |
| 12:34 ET | 300 | 24.43 |
| 12:38 ET | 800 | 24.43 |
| 12:39 ET | 100 | 24.435 |
| 12:43 ET | 836 | 24.46 |
| 12:45 ET | 100 | 24.48 |
| 12:50 ET | 100 | 24.455 |
| 12:54 ET | 300 | 24.43 |
| 12:56 ET | 712 | 24.42 |
| 12:59 ET | 100 | 24.42 |
| 01:01 ET | 14037 | 24.45 |
| 01:06 ET | 200 | 24.45 |
| 01:14 ET | 640 | 24.32 |
| 01:15 ET | 100 | 24.255 |
| 01:17 ET | 800 | 24.15 |
| 01:19 ET | 400 | 24.11 |
| 01:21 ET | 700 | 24.105 |
| 01:24 ET | 1101 | 24.23 |
| 01:26 ET | 900 | 24.24 |
| 01:30 ET | 500 | 24.28 |
| 01:32 ET | 1400 | 24.26 |
| 01:33 ET | 100 | 24.26 |
| 01:35 ET | 900 | 24.285 |
| 01:37 ET | 910 | 24.27 |
| 01:39 ET | 400 | 24.245 |
| 01:42 ET | 400 | 24.245 |
| 01:44 ET | 600 | 24.24 |
| 01:48 ET | 308 | 24.25 |
| 01:50 ET | 2121 | 24.24 |
| 01:51 ET | 200 | 24.215 |
| 01:53 ET | 400 | 24.215 |
| 01:55 ET | 200 | 24.215 |
| 01:57 ET | 300 | 24.15 |
| 02:00 ET | 1108 | 24.135 |
| 02:02 ET | 600 | 24.095 |
| 02:04 ET | 1200 | 24.04 |
| 02:06 ET | 8280 | 24.13 |
| 02:08 ET | 268 | 24.1175 |
| 02:11 ET | 300 | 24.16 |
| 02:13 ET | 1100 | 24.18 |
| 02:15 ET | 100 | 24.18 |
| 02:18 ET | 200 | 24.18 |
| 02:20 ET | 700 | 24.15 |
| 02:22 ET | 300 | 24.08 |
| 02:24 ET | 1000 | 24.1 |
| 02:27 ET | 707 | 24.0675 |
| 02:29 ET | 1800 | 24.11 |
| 02:36 ET | 100 | 24.08 |
| 02:38 ET | 1802 | 24.09 |
| 02:42 ET | 100 | 24.06 |
| 02:44 ET | 1510 | 24.1199 |
| 02:45 ET | 100 | 24.11 |
| 02:47 ET | 400 | 24.1 |
| 02:49 ET | 1608 | 24.07 |
| 02:51 ET | 1838 | 24.07 |
| 02:54 ET | 2923 | 23.905 |
| 02:56 ET | 400 | 23.91 |
| 02:58 ET | 300 | 23.92 |
| 03:00 ET | 3567 | 23.9 |
| 03:02 ET | 200 | 23.9 |
| 03:03 ET | 600 | 23.84 |
| 03:05 ET | 3746 | 24.025 |
| 03:07 ET | 503 | 24.05 |
| 03:12 ET | 1400 | 23.95 |
| 03:14 ET | 100 | 23.955 |
| 03:16 ET | 768 | 23.935 |
| 03:18 ET | 700 | 23.91 |
| 03:20 ET | 1200 | 23.9 |
| 03:21 ET | 700 | 23.85 |
| 03:23 ET | 3855 | 23.88 |
| 03:25 ET | 200 | 23.875 |
| 03:27 ET | 2280 | 23.905 |
| 03:30 ET | 800 | 23.89 |
| 03:32 ET | 1600 | 23.94 |
| 03:34 ET | 200 | 23.97 |
| 03:36 ET | 1676 | 23.96 |
| 03:38 ET | 1308 | 23.895 |
| 03:39 ET | 3318 | 23.87 |
| 03:41 ET | 2200 | 23.94 |
| 03:43 ET | 6202 | 24 |
| 03:45 ET | 2276 | 24.03 |
| 03:48 ET | 1654 | 24.05 |
| 03:50 ET | 3360 | 24 |
| 03:52 ET | 10078 | 24.04 |
| 03:54 ET | 1810 | 24.05 |
| 03:56 ET | 6376 | 24.03 |
| 03:57 ET | 10174 | 24 |
| 03:59 ET | 14397 | 24.03 |
Today
May 29, 2024
Long-Term Data from Mirum's LIVMARLI Studies in ALGS and PFIC to be Presented at EASL Congress, from 8:30AM ET on Wednesday May 29, 2024 by Dow Jones
8:30AM ET on Wednesday May 29, 2024 by Dow Jones
May 18, 2024
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting, from 7:00AM ET on Saturday May 18, 2024 by Dow Jones
7:00AM ET on Saturday May 18, 2024 by Dow Jones
May 10, 2024
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:30PM ET on Friday May 10, 2024 by Dow Jones
7:30PM ET on Friday May 10, 2024 by Dow JonesDJ Mirum Pharmaceuticals Is Maintained at Overweight by Morgan Stanley, from 11:53AM ET on Friday May 10, 2024 by Dow Jones
11:53AM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mirum Pharmaceuticals Inc | 1.2B | -6.3x | --- |
MannKind Corp | 1.2B | 199.3x | --- |
Arcturus Therapeutics Holdings Inc | 1.0B | -9.6x | --- |
Xencor Inc | 1.5B | -10.8x | --- |
Aurinia Pharmaceuticals Inc | 769.4M | -12.4x | --- |
Ginkgo Bioworks Holdings Inc | 1.2B | -1.2x | --- |
Company Information
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. It is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Contact Information
- Headquarters
- 950 Tower Ln Ste 1050FOSTER CITY, CA, United States 94404-4251
- Phone
- 650-667-4085
- Fax
- 302-269-3855
Executives
- Independent Non-Executive Chairman of the Board
- Michael Grey
- President, Chief Operating Officer
- Peter Radovich
- Chief Executive Officer, Co-Founder, Director
- Christopher Peetz
- Chief Financial Officer
- Eric Bjerkholt
- Chief Scientific Officer
- Pamela Vig
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $224.0M |
Shares Outstanding | 47.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-3.82 |
Book Value | $5.32 |
P/E Ratio | -6.3x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -70.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
